Is Alphabet Stock, Like the Market, Oversold Enough to Rally?
Not much changed on Friday. The market is oversold, while sentiment is complacent. We could rally, and a stock I recently recommended could follow.
SpaceX Helps Prevent Pullback With New Price Target
The aerospace firm was among the few AI-related names that carried the day.
The Race Is on for These Two Dividend ETFs. Which Is Best for You?
With a mere $1 billion gap in the way, SCHD is about to dethrone VIG. But bigger isn’t always better.
August Monthly Roundup: Maintaining Our Lead Through the Ups and Downs
We initiated three positions, added to several others, and locked in massive gains along the way.
Are Complacent Investors Setting the Market Up for a Fast and Furious Decline?
The market is down, but investors aren’t scared. Does that mean there’s more downside to come?
Moderna Leads the Charge as Pharma ETF Hits All-Time High
Tempus AI and Merck are key contributors to Moderna’s success.
Weekly Roundup: A Hot Start to August as Portfolio Catches a Wave
We added three new holdings this week, diversifying our lineup, and locked in massive gains across three others.
We’re Initiating New Positions in 2 ETFs
Following our cybersecurity strategy, we’re bringing new end-market exposures to the Portfolio.
Why You Should Think Twice About That 12% ETF Yield
A 12% yield sounds better than 3%, until you look at what’s actually generating each payout.
200+ Nasdaq Stocks Say This Market Isn’t So Great
Between new lows and an increase in downside volume it’s safe to say selling picked up quite a bit Wednesday.